Inactive Instrument
ARYx Therapeutics, Inc. Stock Other OTC
Stocks
ARYX
US0433871094
Biotechnology & Medical Research
OTC Markets Traded| Market Cap | 9.03M 7.82M 7.29M 6.71M 12.66M 859M 12.8M 85.67M 33.59M 430M 33.93M 33.18M 1.42B | P/E 2008 |
-1.76x | P/E 2009 | -2.66x |
|---|---|---|---|---|---|
| Enterprise Value | 11.41M 9.87M 9.2M 8.47M 15.98M 1.08B 16.16M 108M 42.41M 542M 42.83M 41.89M 1.8B | EV / Sales 2008 |
4,019,605x | EV / Sales 2009 | - |
| Free-Float |
100% | Yield 2008 * |
-
| Yield 2009 | - |
| 1 day | +47.06% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +47.06% | +4.62% | - | - | 33 | |
| +4.35% | +19.90% | +60.59% | +95.21% | 62.53B | |
| +2.83% | -3.03% | +27.40% | +67.25% | 52.43B | |
| +0.91% | -0.29% | -16.22% | -13.43% | 23.1B | |
| +0.27% | -4.91% | -10.99% | +350.30% | 21.4B | |
| +0.40% | +5.29% | +30.11% | -9.63% | 21.17B | |
| +0.75% | -0.84% | +33.80% | -25.25% | 17.76B | |
| +9.88% | +19.73% | +229.67% | +385.49% | 15.47B | |
| +2.08% | -3.28% | +21.67% | +564.59% | 14.68B | |
| +1.25% | +0.34% | +54.03% | +179.72% | 14.08B | |
| Average | +6.98% | +3.65% | +47.79% | +177.14% | 26.96B | |
| Weighted average by Cap. | +2.76% | +4.59% | +43.21% | +135.17% |
| 2008 | 2009 | |
|---|---|---|
| Net sales | 19.72 17.07 15.92 14.65 27.63 1.88K 27.95 187.03 73.34 937.88 74.07 72.44 3.11K | - |
| Net income | -31.22M -27.02M -25.19M -23.18M -43.73M -2.97B -44.23M -296M -116M -1.48B -117M -115M -4.92B | -33.17M -28.71M -26.76M -24.63M -46.46M -3.15B -46.99M -315M -123M -1.58B -125M -122M -5.23B |
| Net Debt | -29.9 -25.88 -24.13 -22.21 -41.89 -2.84K -42.37 -283.58 -111.19 -1.42K -112.31 -109.84 -4.72K | 2.37 2.05 1.91 1.76 3.32 225.5 3.36 22.48 8.82 112.74 8.9 8.71 373.85 |
Employees
-
